92 IMPACT OF COMORBIDITIES AND GERIATRIC ASSESSMENT IN HIGH RISK MYELODYSPLASTIC SYNDROMES OVER 75 YEARS TREATED WITH AZACITIDINE. Issue 1 (April 2015)